On 13 November 2015, the Biomarker Bay contract between the University Medical Center (UMCG), the University of Groningen (RuG) and the five clinical research organizations QPS, ABL, Syncom, IQ products and BrainsOnline has been signed. BBay is officially born!
The region of Northern Netherlands is highly active in the field of biomarker research, drug discovery, early disease diagnosis and health care. BiomarkerBay combines the expertise, the high quality competences and the top-notch research from academia, bioanalytical companies, contract research organizations and the University Medical Center in Groningen into a unique joint platform. By bringing together academic labs and contract research to join forces and cooperate in the field of biomarkers and bioanalysis, BiomarkerBay aims to increase efficiency of the use of combined knowledge, to develop highly advanced lab technologies and jointly offer high quality and competitive biomarker services to the market, in turn creating new opportunities and synergies between academia and industries and stimulating growth in the life science business sector in the region. With the signing of the contract the first building block for the BiomarkerBay initiative has been laid down. In the upcoming months, the BiomarkerBay organization will be shape further.
To know more about BiomarkerBay, please click here.
